EGM
SRPT icon

Engineers Gate Manager’s Sarepta Therapeutics SRPT Stock Holding History

Engineers Gate Manager’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,258
Closed -$354K – 2597
2026
Q1 		$354K Buy
+16,258
New +$315K ﹤0.01% 1621
2025
Q4 		– Sell
-153,257
Closed -$2.95M – 2520
2025
Q3 		$2.95M Buy
153,257
+10,430
+7% +$186K 0.03% 585
2025
Q2 		$2.44M Buy
142,827
+67,430
+89% +$2.88M 0.03% 649
2025
Q1 		$4.81M Buy
+75,397
New +$7.94M 0.08% 342
2024
Q4 		– Sell
-5,475
Closed -$684K – 2554
2024
Q3 		$684K Buy
+5,475
New +$757K 0.01% 1223
2024
Q2 		– Sell
-12,354
Closed -$1.6M – 2216
2024
Q1 		$1.6M Sell
12,354
-14,806
-55% -$1.81M 0.04% 582
2023
Q4 		$2.62M Buy
+27,160
New +$2.61M 0.07% 367
2023
Q3 		– Sell
-14,599
Closed -$1.67M – 2066
2023
Q2 		$1.67M Sell
14,599
-15,998
-52% -$2.06M 0.06% 425
2023
Q1 		$4.22M Buy
30,597
+26,465
+640% +$3.43M 0.18% 139
2022
Q4 		$535K Buy
+4,132
New +$479K 0.03% 853
2022
Q3 		– Sell
-6,590
Closed -$494K – 2048
2022
Q2 		$494K Sell
6,590
-3,162
-32% -$233K 0.02% 1120
2022
Q1 		$762K Buy
+9,752
New +$747K 0.03% 825
2021
Q3 		– Sell
-22,075
Closed -$1.72M – 1958
2021
Q2 		$1.72M Buy
22,075
+9,675
+78% +$733K 0.11% 219
2021
Q1 		$924K Buy
+12,400
New +$1.14M 0.05% 619
2020
Q4 		– Sell
-8,030
Closed -$1.13M – 1966
2020
Q3 		$1.13M Buy
8,030
+1,111
+16% +$169K 0.05% 548
2020
Q2 		$1.11M Buy
6,919
+3,185
+85% +$433K 0.06% 560
2020
Q1 		$365K Buy
+3,734
New +$427K 0.03% 939

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Engineers Gate Manager's SRPT Position: Q2 2026 in Review

Engineers Gate Manager sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 16,258 shares — an estimated $354K sold.

Engineers Gate Manager first reported a position in SRPT in Q1 2020 and held it in 17 quarters. The position peaked at $4.81M in Q1 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Engineers Gate Manager reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 16,258 Sarepta Therapeutics shares in Q2 2026, an estimated $354K.
  • Engineers Gate Manager first reported a position in Sarepta Therapeutics in Q1 2020 and held it in 17 quarters.
  • Engineers Gate Manager's Sarepta Therapeutics position peaked at $4.81M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.